| Financial Year |
March 31 2023 |
| Monetary Funds |
4,135,912,849.98 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
997,269,032.18 |
| Accounts Receivable |
39,540,909.24 |
| Advances to Suppliers |
58,782,465.03 |
| Other Receivables |
31,983,884.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
4,527,000.66 |
| Dividend Receivable |
-- |
| Inventories |
2,280,679,350.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,693,628.38 |
| Total Current Assets |
7,626,284,763.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
70,759,632.69 |
| Fixed Assetes |
2,526,341,513.80 |
| Under-construction Projects |
1,676,419,159.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
455,672,233.45 |
| R&D expenses |
526,099,579.48 |
| Goodwill |
173,924,750.15 |
| Long-Term Deferred and Prepaid Expenses |
60,979,725.80 |
| Deferred Income Tax Assets |
73,198,554.63 |
| Other Non-Current Assets |
130,023,933.68 |
| Sub-Total of Non-Current Assets |
5,886,635,319.25 |
| Total Assets |
13,512,920,082.80 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,382,932.00 |
| Accounts Payable |
83,071,165.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
95,568,480.86 |
| Taxes Payable |
107,993,779.40 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
572,636,820.74 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
121,765,703.11 |
| Other Current Liabilities |
11,090,080.00 |
| Sub-Total of Current Liabilities |
1,365,270,017.66 |
| Long-term Loans |
253,750,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
41,353,268.96 |
| Other Non-Current Liabilities |
4,104,759.60 |
| Sub-Total of Non-Current Liabilities |
432,328,107.38 |
| Total Liabilities |
1,797,598,125.04 |
| Paid-In Capital(Or Share Stock) |
1,647,809,538.00 |
| Capital Surplus |
2,792,640,642.07 |
| Surplus Reserve |
259,428,715.06 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,357,874,674.74 |
| Minority Stockholder's Interest |
2,657,672,592.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,057,649,364.87 |
| Owner's Equity（Stockholder's Equity） |
11,715,321,957.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,512,920,082.80 |
